MedTrace Logo

Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness

NCT03270787 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2017-09-01

No results posted yet for this study

Summary

This study is to evaluate the efficacy and safety of compound danshen dripping pills in preventing and treating acute mountain sickness.

Conditions

  • Acute Mountain Sickness

Interventions

DRUG

Placebo

Drug: Placebo Placebo,10pills,tid,treat 1 weeks.

DRUG

Compound danshen dripping pills

Drug: Compound danshen dripping pills Compound danshen dripping pills,10pills,tid,treat 1 weeks.

Sponsors & Collaborators

  • Tasly Pharmaceuticals, Inc.

    lead INDUSTRY

Principal Investigators

  • Min Zhao, PhD · Tasly Group, Co. Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-24
Primary Completion
2016-07-13
Completion
2017-07-13

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03270787 on ClinicalTrials.gov